Meta-analysis: Test performance of ultrasonography for giant-cell arteritis

被引:276
作者
Karassa, FB
Matsagas, MI
Schmidt, WA
Ioannidis, JPA [1 ]
机构
[1] Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, GR-45110 Ioannina, Greece
[2] Fdn Res & Technol, Ioannina, Greece
[3] Med Ctr Rheumatol Berlin, Berlin, Germany
[4] Tufts Univ, Sch Med, Tufts New England Med Ctr, Boston, MA USA
关键词
D O I
10.7326/0003-4819-142-5-200503010-00011
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Giant-cell arteritis is a diagnostic challenge. Purpose: To determine the diagnostic performance of ultrasonography for giant-cell arteritis. Data Sources: Studies published up to April 2004 in the MEDLINE, EMBASE, and Cochrane databases; reference lists; and direct contact with investigators. Study Selection: Studies in any language that examined temporal artery ultrasonography for diagnosis of giant-cell arteritis, enrolled at least 5 patients, and used biopsy or the American College of Rheumatology (ACR) criteria as the reference standard. Data Extraction: Two reviewers independently graded methodologic quality and abstracted data on sensitivity and specificity of ultrasonography for giant-cell arteritis. Diagnostic performance was determined for the halo sign, stenosis, or occlusion and for any of these ultrasonographic abnormalities. Data Synthesis: Weighted sensitivity and specificity estimates and summary receiver-operating characteristic (ROC) curve analysis were used. Twenty-three studies, involving a total of 2036 patients, met the inclusion criteria. The weighted sensitivity and specificity of the halo sign were 69% (95% Cl, 57% to 79%) and 82% (Cl, 75% to 87%), respectively, compared with biopsy and 55% (Cl, 36% to 73%) and 94% (Cl, 82% to 98%), respectively, compared with ACR criteria. Stenosis or occlusion was an almost equally sensitive marker compared with either biopsy (sensitivity, 68% [Cl, 49% to 82%]) or ACR criteria (sensitivity, 66% [Cl, 32% to 89%]). Consideration of any vessel abnormality nonsignificantly improved diagnostic performance compared with ACR criteria. Between-study heterogeneity was significant, but summary ROC curves were consistent with weighted estimates. When the pretest probability of giant-cell arteritis is 10%, negative results on ultrasonography practically exclude the disease (post-test probability, 2% to 5% for various analyses). Limitations: The primary studies were small and of modest quality and had considerable heterogeneity. Conclusion: Ultrasonography may be helpful in diagnosing giant-cell arteritis, but cautious interpretation of the test results based on clinical presentation and pretest probability of the disease is imperative.
引用
收藏
页码:359 / 369
页数:11
相关论文
共 56 条
[1]  
Aburahma AF, 1996, AM SURGEON, V62, P449
[2]   HOW DOES PREVIOUS CORTICOSTEROID TREATMENT AFFECT THE BIOPSY FINDINGS IN GIANT-CELL (TEMPORAL) ARTERITIS [J].
ACHKAR, AA ;
LIE, JT ;
HUNDER, GG ;
OFALLON, WM ;
GABRIEL, SE .
ANNALS OF INTERNAL MEDICINE, 1994, 120 (12) :987-992
[3]   THE USE OF DOPPLER FLOW STUDIES IN THE DIAGNOSIS OF GIANT-CELL ARTERITIS - SELECTION OF TEMPORAL ARTERY BIOPSY SITE IS FACILITATED [J].
BARRIER, J ;
POTEL, G ;
RENAUTHOVASSE, H ;
HANH, TH ;
PELTIER, P ;
CHAMARY, V ;
GROLLEAU, JY .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1982, 248 (17) :2158-2159
[4]   Facial nerve injury following superficial temporal artery biopsy [J].
Bhatti, MT ;
Goldstein, MH .
DERMATOLOGIC SURGERY, 2001, 27 (01) :15-17
[5]   DOPPLER SONOGRAPHIC FINDINGS IN TEMPORAL ARTERITIS [J].
BRUNHOLZL, C ;
MULLER, HR .
ULTRASCHALL IN DER MEDIZIN, 1988, 9 (05) :232-236
[6]  
DANY F, 1989, J MAL VASCUL, V14, P104
[7]   Publications on diagnostic test evaluation in family medicine journals:: an optimal search strategy [J].
Devillé, WLJM ;
Bezemer, PD ;
Bouter, LM .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 2000, 53 (01) :65-69
[8]  
DORNBERGER V, 1987, MED WELT, V38, P1302
[9]  
FISHER CM, 1971, T AM NEUROL ASSOC, V96, P12
[10]  
Fleiss J L, 1993, Stat Methods Med Res, V2, P121, DOI 10.1177/096228029300200202